Market Overview:
The global magnetic beads market size reached US$ 2.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2028, exhibiting a growth rate (CAGR) of 12.41% during 2023-2028.
Magnetic beads are tiny particles of iron oxides used in molecular biology for easy and effective isolation of biomolecules. They provide a simple and reliable method of purifying plasmids, genomic and mitochondrial deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. They are widely utilized in next-generation sequencing (NGS), polymerase chain reaction (PCR), quantitative PCR (qPCR), droplet digital PCR (ddPCR) and other amplification and genotyping applications. They can also find applications as carriers of antigens, antibodies, and catalyzers for tissue-specific targeting and in magnetic resonance imaging (MRI, magnetic particle imaging, and nanomaterial-based catalysis worldwide.
Magnetic Beads Market Trends:
Molecular biology and nanotechnology-based analytical methods are nowadays employed as diagnostic tools for the rapid screening of coronavirus disease (COVID-19) with high accuracy and precision. This represents one of the major factors driving the need for magnetic beads across the globe. Apart from this, the rising preference for in-vitro diagnostic testing on account of their versatility and ability to provide quick results is impelling the market growth. Moreover, a significant increase in the human lifespan and aging of the baby boomer generation is catalyzing the demand for medicines and other studies targeting chronic diseases. This, in turn, is positively influencing the demand for magnetic beads to facilitate disease prevention and treatment methods and the generation of new protein products. Besides this, researchers are studying the efficacy of magnetic beads containing graphite carbon on removing color and organic substances in livestock wastewater. Such innovations are creating a positive influence on the usage of magnetic beads in the agriculture sector. Furthermore, rising investments in genetic and microbiology research activities are projected to provide a thrust to the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global magnetic beads market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, magnetic core, size and application.
Breakup by Type:
- Cells
- Pathogenic Microorganisms
- Nucleic Acids
- Peptide
- Protein
- Others
Breakup by Magnetic Core:
- Superparamagnetic
- Ferrimagnetic
Breakup by Size:
- Less than 5 μm
- 5-20 μm
- 20-40 μm
- 40 μm and Above
Breakup by Application:
- Next-Generation Sequencing
- Biomolecules Separation and Purification
- Molecular and Immunodiagnostics
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced BioChemicals LLC, Bio-Rad Laboratories Inc., Calbiotech Inc, MagBio Genomics Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Vazyme Biotech Co. Ltd., and Xiamen Zeesan Biotech Co. Ltd.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Type, Magnetic Core, Size, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Advanced BioChemicals LLC, Bio-Rad Laboratories Inc., Calbiotech Inc, MagBio Genomics Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Vazyme Biotech Co. Ltd., and Xiamen Zeesan Biotech Co. Ltd. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |